Previous Article | Next Article ![]()
Applied and Environmental Microbiology, January 2002, p. 143-151, Vol. 68, No. 1
0099-2240/02/$04.00+0 DOI: 10.1128/AEM.68.1.143-151.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Molecular Plant-Microbe Interactions Laboratory, Department of Biological Sciences, National University of Singapore, Singapore 117 543
Received 12 June 2001/ Accepted 11 October 2001
|
|
|---|
|
|
|---|
Several microbes, such as Rhizobia, Agrobacterium, Pseudomonas, Bacillus, and Rhodococcus spp., that exist in the rhizosphere are known to participate in the breakdown or degradation of flavonoids (2, 3). Although, some mechanisms have been proposed, the pathways were not elucidated. A survey of flavonoid-degrading rhizobial strains revealed that flavonoids were generally cleaved via C-ring fission (38, 39). In particular, there is a dearth of information on the biochemical and genetic aspects of catabolism of flavonoids in Pseudomonas spp. An early study on flavonoid degradation by a soil pseudomonad speculated on the presence of oxygenases based on the oxidation products and proposed that the degradation proceeded via protocatechuate production (46). The anaerobic degradation of flavonoids by the intestinal microflora, in comparison to the aerobic pathways, has been well documented, and several reports describe the reduction and dehydroxylation reactions leading to phloroglucinol formation (10, 15, 26, 43, 44, 54, 55).
This study was undertaken to elucidate the pathway for utilization of the archetypal flavonoid, quercetin, in a plant growth-promoting rhizobacterial (PGPR) strain of Pseudomonas putida which can also grow on naringenin, daidzein, apigenin, hespertin, naringin, protocatechuate, p-hydroxy benzaldehyde, or p-hydroxy benzoic acid as the sole carbon source. In order to understand the catabolism of quercetin in Pseudomonas, we constructed several transposon insertion mutants defective in flavonoid catabolism and compared the metabolic profiles of pathway intermediates in the cultures of wild-type and three mutant strains by using high-pressure liquid chromatography (HPLC), mass spectrometry (MS), and nuclear magnetic resonance (NMR) spectroscopy. We report for the first time the conversion of quercetin to naringenin by a soil pseudomonad involving dehydroxylation in aerobic conditions. Subsequent events such as hydrolysis and oxidation lead to formation of protocatechuate that is channelled into the tricarboxylic acid (TCA) cycle via the meta-cleavage pathway.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Bacterial strains used in this investigation and their properties
|
-toluic acid), 3,4-dihydroxybenzaldehyde, 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid), 3-hydroxybenzoic acid, 3-(4-hydroxyphenyl)propionic acid (phloretinic acid), 4-methyl-1,2-benzenediol (4-methyl catechol), 3-hydroxycinnamic acid, 3,4-dihydroxycinnamic acid (caffeic acid), and 2,4-dihydroxybenzoic acid were obtained from Aldrich Chemical Co. (Milwaukee, Wis.). Flavonoid stock solutions (10 mM) were prepared in alkalized methanol under liquid nitrogen conditions and filter sterilized prior to addition to media. All flavonoid solutions were stored in the dark at 4°C to prevent photosensitive reactions from occurring. Pure water (18 m
resistance) was used throughout the experiments. Deuterated dimethyl sulfoxide (DMSO; 99.9%) was obtained from Aldrich and used as the solvent in NMR analysis. Deuterated water was used to blank water peaks, if any.
![]() View larger version (9K): [in a new window] |
FIG. 1. Structures of parent compounds used in screening for flavonoid auxotrophy in this study. (A) 3,3',4',5,7-Pentahydroxy flavone (quercetin dihydrate) (molecular weight, 338.4). (B) 4',5,7-Trihydroxyflavanone (naringenin) (molecular weight, 272.3).
|
pir) into P. putida strain PML2. Mutagenesis with mini-Tn5gfp was achieved by mixing 4 x 107 Escherichia coli SM10 (
pir) donor cells and 107 recipient cells of P. putida strain PML2 on antibiotic-free tryptic soy agar plates. After 5 h of incubation at 30°C, the cells were harvested and suspended in 0.8% saline, and subsequent dilutions were plated on SM (48) containing 0.5% glycerol as the carbon source, along with the antibiotics chloramphenicol and gentamicin as indicated. Colonies emerging on this medium were screened by replica plating them for auxotrophy to 10 mM flavonoids (quercetin). Mutant strains with the inability to grow on SM plates containing 10 mM flavonoids as the carbon source were chosen for further experiments. In order to calculate the rate of spontaneous mutations, 108 cells of P. putida PML2 (wild type) were spread on plates containing 10 mM flavonoids, and those not able to grow were assumed to be spontaneous mutants.
Growth experiments and depletion studies.
Growth studies of PGPR P. putida PML2 wild-type and mutant strains were done in SM supplemented with 10 mM flavonoids (quercetin and naringenin; Fig. 1) as the carbon source (SMF). Cultures grown to an A600 of 0.2 in SM supplemented with glycerol (SMG) were diluted 10-fold for inoculating SMF. Growth was monitored by measuring the absorbance at 600 nm. Growth in other aromatic metabolites, such as naringenin, 3,4-dihydroxycinnamic acid, phloroglucinol, protocatechuate, p-hydroxybenzaldehyde, and p-hydroxybenzoic acid (Fig. 2) at 10 mM concentrations was studied as described above. Colony counts from plating appropriate serial dilutions were performed to further confirm the growth of wild-type and mutant strains in SMF. All counts were performed at least in triplicate, and the experiments were performed three times. Statistical analyses were performed on all data. The mean and standard error results of these values were calculated after log10 transformations.
![]() View larger version (29K): [in a new window] |
FIG. 2. Structures of chemicals and intermediates used in this study. MW, molecular weight.
|
Confirmation of mini-Tn5gfp insertions.
Chromosomal DNA was prepared as previously described (50), and standard recombinant DNA techniques were used according to the method of Sambrook et al. (40). PCR was carried out with transposon-specific primers to confirm the presence of transposon DNA in the mutant strains. The primer sequences were derived from mini-Tn5gfp sequence (49) for the gfp and gentamicin resistance (Gmr) genes (GenBank accession numbers U62636 and P23181, respectively) and were as follows: GfpF, 5'-GGAGAAGAACTTTTCACTGGAG-3'; GfpR, 5'-TTGTAGAGCTCATCCATGCCAT-3'; GmF, 5'-AGGTGGCGGTACTTGGGTC-3'; and GmR, 5'-AGAACCTTGACCGAACGC-3'. Southern blotting was performed to characterize the transposon mutants. Genomic DNAs from P. putida strain PML2 and its mutant strains were digested with the restriction enzyme BglII or KpnI (Fermentas AB, Vilnius, Lithuania). Transfer of DNA to a nylon membrane (Hybond+; Amersham Pharmacia Biotech UK, Ltd.) from agarose gels and hybridization conditions were in accordance with the manufacturers recommendations. Hybridization was done by using a digoxigenin-labeled PCR fragment of the transposon as the probe and visualized with nitroblue tetrazolium-BCIP (5-bromo-4-chloro-3-indolylphosphate) and CSPD (Boehringer Mannheim, GmbH, Mannheim, Germany), as recommended by the manufacturer.
Flavonoid degradation experiments.
The degradation experiments were performed with 200-ml cultures grown in 500-ml Erlenmeyer flasks. These flasks were inoculated with a 10-fold dilution of an overnight-grown culture adjusted to an A600 of 0.2 wrapped in aluminum foil, and incubated at 30°C on a rotary shaker (220 rpm). Samples were collected periodically and initially centrifuged at 16,800 x g for 20 min at 4°C, and the whole-cell supernatant was separated. The pelleted cells were lysed by using a SIM-Aminco French Pressure Cell (Spectronic Instruments, Inc., Rochester, N.Y.) at 1,000 lb/in2 in 0.5 M phosphate buffer. The resulting crude cell lysate was further centrifuged at 16,800 x g for 20 min at 4°C to separate the cell debris from the cleared lysate. The whole-cell supernatant, crude debris fraction, and cleared cell lysate were thus collected and stored at 80°C in the dark till further use. Frozen samples of these fractions were used for the analysis of substrates and degradation products. Prior to experiments, methanol was added to 50% (vol/vol) to the samples to achieve efficient extraction of the phenolic flavonoids and their respective intermediates. Extracts were filtered with a 0.45-µm-pore-size polytetrafluoroethylene membrane filter (Nalge Co., Rochester, N.Y.), and aliquots of 1.5 to 2.0 ml were subjected to reversed-phase (RP)-HPLC to detect the presence of various breakdown products. Uninoculated control flasks were used to identify spontaneous changes in the supplemented metabolites.
RP-HPLC analysis.
Chromatographic analysis was carried out with a Vision Bio-Cad RP-HPLC workstation BIOCAD 700E equipped with a dual-pump system (PerSeptive Biosystems, Foster City, Calif.), a diode-array detector UVD-320, and a Hypersil C18 RP column (250 by 4.6 mm) with a particle size of 5 µm (catalog no. 00G-4053-E0; Phenomenex). The column temperature was maintained at 25°C. Sample volume was kept constant at 1.5 ml for each injection, while the solvent flow rate was maintained at 0.60 ml/min. For all compounds, a gradient was used starting with HPLC-grade water (pH 3.0 adjusted with glacial acetic acid), with an increasing concentration of HPLC-grade 100% acetonitrile (a linear gradient of 1 to 10% for 4 min, a linear gradient of 10 to 60% for 60 min, followed by a 2-min linear step to 100% acetonitrile which was maintained for 2 min, and a further 2-min linear step back to 100% [pH 3.0] water). Standards of various aromatic compounds such as pyrogallol, protocatechuate, 3,4-dihydroxyphenylacetic acid, 3-hydroxyphenylacetic acid, 4-phenylacetic acid, 3,4-dihydroxybenzaldehyde, homovanillic acid, 3-hydroxybenzoic acid, phloretinic acid, 4-methyl catechol, 3-hydroxycinnamic acid, 3,4-dihydroxycinnamic acid, phloroglucinol, and 2,4-dihydroxybenzoic acid were tested as possible metabolic intermediates. Chromatographic profiles of eluting compounds were obtained at appropriate dual wavelengths determined based on absorption spectral scans that ranged from 200 to 600 nm. The HPLC fractions and compounds were identified by their retention times and UV spectra in comparison to those of their corresponding standards. Fractions corresponding to the individual peaks were collected and processed separately for further analysis by MS. Controls and blanks were used prior to loading the samples. Typical HPLC profiles were established based on a minimum of four runs from three independent experiments.
ESI-MS analysis.
Fractions resolved by RP-HPLC were freeze-dried, concentrated, and resuspended in 50 µl of HPLC-grade methanol before injection into the electrospray ionization (ESI) mass spectrometer. A PE Sciex API300 LC/MS (PE Sciex, Toronto, Ontario, Canada) single-quadrupole instrument equipped with an electron spray ion source was used for analysis of masses of the breakdown products. All MS analyses were carried out in the positive ionization mode. The ring voltage was 150 V, and the mobile phase was a gradient of 1:1 acetonitrile-water containing 1 mM ammonium acetate. An Apple Macintosh system 8.1 with Mass Chrom (PE Sciex) software was used for data acquisition and processing. Spectra were analyzed and interpreted using BioMultiview 1.3 (PE Sciex). Sample analysis was performed in triplicates.
NMR analysis.
NMR measurements were carried out with a 300-MHz Bruker ACF300 (Bruker Analytik GmbH, Rheinstetten, Germany) equipped with an autotunable 5-mm Quad-Nuclei QNP probe for the detection of 1H, 13C, 19F, and 31P, with a variable temperature facility. A sample changer was used to perform one-dimensional NMR scans for 1-h time periods. 1H and 13C NMR spectra were recorded at 298 K. All of the samples were dissolved in deuterated DMSO (DMSO-d6). The chemical shifts were expressed as
values (parts per million) by using the solvent as an internal reference (DMSO-d6:
H = 16.22,
C = 77.40). The spectral width was set at 200 ppm. Deuterated water was used to blank water peaks.
|
|
|---|
pir) strain. Three independently derived flavonoid-auxotrophic strains that were identified based on their inability to grow on quercetin- and naringenin-containing medium were designated Flav-1 to -3 and were chosen for further studies (Table 2). |
View this table: [in a new window] |
TABLE 2. Growth characteristics of wild-type P. putida PML2 strain and Flav mutant strains in different carbon sources at 60 h postinoculationa
|
Growth studies of wild-type strain PML2 and its three Flav mutants in SM containing 10 mM quercetin (SMQ) (Fig. 3A) and in SMG (Fig. 3D) were monitored over a 60-h time period. In SMG, these three mutant strains had growth comparable to that of the wild-type strain PML2, although its growth in naringenin was moderately low (Fig. 3C). However, the three Flav strains still showed distinctly slow or no growth in this substrate.
![]() View larger version (29K): [in a new window] |
FIG. 3. Growth and depletion studies. (A) Growth of wild type ( ) and mutant strains Flav-1 ( ), Flav-2 ( ), and Flav-3 () in SMQ. The "A600" in the y axis indicates absorbance values recorded at 600 nm. (B) Degradation of 0.1 mM flavonoid by wild-type P. putida PML2 in the cell soluble fractions of SMQ supernatant ( ). The growth curve of the wild-type strain PML2 ( ) and the flavonoid mutant strains Flav-1 ( ), Flav-2 ( ), and Flav-3 () are shown. The primary y axis shows the absorbance values recorded at 600 nm, indicated as "A600." The percent depletion refers to the decrease in flavonoid concentrations over a period of time and is shown in the secondary y axis. (C) Growth of wild type ( ) and mutant strains Flav-1 ( ), Flav-2 ( ), and Flav-3 () in SM supplemented with 10 mM naringenin. The "A600" in the y axis indicates absorbance values recorded at 600 nm. (D) Growth of wild type ( ) and mutants Flav-1 ( ), Flav-2 ( ), and Flav-3 () in SM supplemented with 0.5% glycerol as the carbon source. The "A600" in the y axis indicates absorbance values recorded at 600 nm.
|
Confirmation of transposon insertions.
The presence of mini-Tn5gfp was studied in the three Flav strains by using DNA amplification and hybridization-based assays. DNA amplifications with transposon-specific primers (Gmr and gfp genes, respectively) were used to confirm mini-Tn5gfp integration into the genome. The expected 0.7-kb DNA fragments from either gene were observed in Flav-1, -2, and -3 strains but not in the wild-type genomic DNA (data not shown). DNA gel blot analysis was used to determine both the number of mini-Tn5gfp insertions and their positions in the genome. Hybridization of a Southern blot of three Flav strains genomic DNA digested with KpnI or BglII that cut once in the transposon showed only single bands of different sizes. The corresponding lanes for wild-type strain PML2 did not show any signal, as expected (data not shown). This indicated that mini-Tn5gfp had been inserted as a single copy in random locations in the three Flav strains.
RP-HPLC analysis of flavonoid degradation products.
In order to understand quercetin catabolism, flavonoid-utilization-defective mutants were used in comparative metabolic profiling. A maximum of seven peaks could be resolved in the case of cell soluble fractions, followed by two peaks from supernatant samples, whereas cell debris had no detectable metabolites. The two peaks from the supernatant belonged to quercetin and naringenin based on MS results and comparison with results for commercially available standards (data not shown). This profile remained the same throughout the 7 days of the study period. Methanolic extracts of cell soluble fractions from the wild type and Flav-1 strain were compared at 0, 2, and 7 days postinoculation since these were the most informative based on the number of peaks resolved. In comparison to the changing profile of metabolites from the wild-type samples (Fig. 4A to C), those from the mutant strain remained mostly unchanged over a comparable period of time (Fig. 4D to F). The fractions (belonging to the ancillary peaks) were also collected and analyzed by MS and found to have low ionization. The compounds were therefore not detected and thus determined to be insignificant. In the case of wild-type samples, six unique peaks were detected at 2 days (Fig. 4B) postinoculation compared to that of the day zero control (Fig. 4A). Most of these peaks were undetectable in samples collected at day 7. We reasoned that metabolites corresponding to these six peaks had accumulated as a result of flavonoid degradation by P. putida PML2 since quercetin degradation occurs rapidly within 60 h postinoculation (Fig. 3B). Metabolites corresponding to the six peaks from day 2 samples of wild-type culture were analyzed by MS (described below). Based on the tentative identities of the six major metabolites, four commercially available pure standards were used to compare their HPLC profiles with those of the samples from cell soluble fractions. These four metabolites were naringenin (retention time, 13 min), 3,4-dihydroxy cinnamic acid (retention time, 12 min), phloroglucinol (retention time, 9 min), and protocatechuate (retention time, 7.5 min). Peaks assigned to these metabolites are based on both comparison with pure standards and MS. The major HPLC peak, excluding that of the substrate, is of naringenin, which was also detected in the whole-cell supernatant. The fact that six peaks identified from the day 2 wild-type cultures were absent in the samples from the mutant strain showed that these compounds were not a result of spontaneous oxidation events.
![]() View larger version (27K): [in a new window] |
FIG. 4. RP-HPLC elution profiles of phenolic fractions from the cell soluble fractions of wild-type and mutant cultures at different time points of growth. "A286" in the y axis indicates the wavelength (286 nm) used for detection. (A) Wild-type culture samples on day 0 (W-0d). (B) Wild-type culture sample at day 2 (W-2d). (C) Wild-type culture sample on day 7 (W-7d). (D) Flav mutant culture sample at day 0 (M-0d). (E) Flav mutant culture sample at day 2 (M-2d). (F) Flav mutant culture sample on day 7 (M-7d).
|
NMR analysis and identification of metabolites.
Four individual fractions identified by ESI-MS were subjected to one-dimensional NMR analysis in a DMSO-d6 solvent system. 1H- and 13C-NMR measurements were carried out, and the NMR spectra were recorded at 298 K. Chemical shifts were expressed as
values by using the solvent as an internal reference (DMSO-d6:
H = 16.22,
C = 77.40). Based on the NMR data and the m/z values, the structures of the compounds were confirmed. They were identified as naringenin (4',5,7-trihydroxy flavanone) with
H values of 5.45, 5.80, 5.80, 6.70, 6.80, 7.29, and 7.30 ppm and
C values of 78.3, 94.8, 95.6, 98.0, 98.3, 105.0, 114.9, 115.0, 128.2, 128.7, 157.6, 162.8, 163.3, 166.5, and 196.2 ppm; caffeic acid (3,4-dihydroxycinnamic acid) with
H values of 6.2, 6.7, 6.9, 7.0, and 7.45 ppm and
C values of 114.0, 115.0, 115.6, 121.0, 125.6, 144.4, 145.0, 147.9, and 167.7 ppm; 2,4,6-trihydroxy benzene (phloroglucinol) with
H values of 5.65, 5.65, and 5.65 ppm and
C values of 93.9, 93.9, and 93.9 ppm; and 3,4-dihydroxy benzoic acid (protocatechuate) with
H values of 6.8, 7.2, and 7.3 ppm and
C values of 115.0, 116.0, 120.0, 120.0, 144.0, 150.0, and 166.0 ppm.
Growth in metabolic intermediates.
We studied the growth of wild-type PML2 and Flav-1, -2, and -3 strains in three aromatic intermediates determined by the above-described studies: 3,4-dihydroxycinnamic acid, phloroglucinol, and protocatechuate. The wild-type strain and mutant strains had comparable levels of growth in SM supplemented with 3,4-dihydroxycinnamic acid, phloroglucinol, and protocatechuate (Fig. 5). Both the wild-type PML2 and Flav strains reached a maximum A600 value of 0.06 in SM supplemented with dihydroxycinnamic acid (Fig. 5A-CIN) and phloroglucinol (Fig. 5B-PHL), while the A600 values attained by both wild-type and mutant strains in protocatechuate were slightly greater than 0.25 (Fig. 5C-PTC), indicating that protocatechuate could be the physiologically preferred substrate, while 3,4-dihydroxycinnamic acid and phloroglucinol are not. Taken together with data shown in Fig. 3, it is seen that among the four intermediates detected in this study, Flav-1, -2, and -3 mutant strains were unable to utilize three of them, placing their respective blocks in the flavonoid degradation pathway before protocatechuate formation. Studies to characterize the flavonoid catabolic genes in P. putida PML2 are in progress.
![]() View larger version (16K): [in a new window] |
FIG. 5. Growth of wild type ( ) and mutant strains Flav-1 ( ), Flav-2 ( ), and Flav-3 () in SM supplemented with different metabolic intermediates (10 mM). The "A600" in the y axis indicates absorbance values recorded at 600 nm. (A-CIN) Growth in 3,4-dihydroxycinnamic acid. Slower growth is seen. (B-PHL) Growth in phloroglucinol. Slower growth is seen. (C-PTC) Growth in protocatechuate. A relatively higher growth of wild-type and mutant strains than on the other two substrates can be seen.
|
|
|
|---|
A pathway is described here for the degradation of quercetin by P. putida. The results based on the identification of metabolic intermediates and accumulation of end products validates this pathway (Fig. 6). The initial step in the degradation of quercetin in most of the aerobic pathways involves oxidation and/or reduction reactions of the parent molecule that leads to the formation of protocatechuate or catechol. It is interesting to note the initial reaction of 3,3'-didehydroxylation in the above pathway. This, as an initial step, is unusual for aerobic reactions and has been reported from rare cases. Previously, 7
-dehydroxylation of cholic acid by Eubacterium and Clostridium spp. (4, 14) and 21-dehydroxylation of deoxycorticosterone by Clostridium paraputrificium have been reported in anaerobic environments (6). Our results clearly show that quercetin is dehydroxylated to naringenin before being converted further to smaller compounds. The P. putida pathway described here, therefore, shows a general reversal compared to the flavonoid biosynthetic pathway in plants, where quercetin is formed by hydroxylation of naringenin by the enzyme flavanone-3-hydroxylase. In plants, the pentahydroxy molecule quercetin undergoes further reactions to produce more stable compounds such as tannins, cyanidin, and anthocyanins. In P. putida PML2, quercetin degradation follows the same convergence to protocatechuate-mediated breakdown as seen in the upper pathways for the degradation of 4-coumerate, 4-chlorobenzoate, cyclohexane carboxylate, shikimate, 4-hydroxybenzoate, quinate, benzoate, vanillate, ferulate, coniferyl alcohol, p-cresol, and several others (reviewed in reference 21).
![]() View larger version (15K): [in a new window] |
FIG. 6. Quercetin degradation pathway in P. putida strain PML2. (I) Quercetin (3,3',4',5,7-pentahydroxy flavone). (II) Naringenin (4',5,7-trihydroxy flavanone). (III) Unstable intermediate (transient product; detected by mass spectrometry). (IVa) Phloroglucinol. (IVb) 3,4-Dihydroxy cinnamic acid. (V) 3,4-Dihydroxy styrene. (VI) Protocatechuic aldehyde. (VII) Protocatechuic acid. The identity of all compounds except compounds III, V, and VI was confirmed by NMR spectroscopy. All compounds were detected in the wild-type strain PML2 but not in the Flav-1, -2, and -3 strains and are stably formed except for compound III. Hydrolysis and cleavage of ether and keto bonds and the presence of an unstable intermediate (compound III) have been inferred based on the structures of compounds II and IV.
|
The B-ring intermediate 3,4-dihydroxycinnamic acid undergoes decarboxylation in aerobic conditions to yield 3,4-dihydroxystyrene and CO2 according to the pathway described here. Styrene has been previously shown to occur naturally in the environment as a result of decarboxylation of cinnamic acid and formaldehyde (45). Two major routes of aerobic styrene degradation are known to exist in several microbes (1, 20, 52) but proceed via an initial side chain oxidation leading to the formation of phenylacetic acid in the genus Pseudomonas (33). Another recent study based on ESI-MS of flavonoid molecules suggested the formation of such stable ortho-dihydroxylated compounds due to the loss of CO and H from similar metabolites to form a nonaromatic acid (25). In our case, oxidation of the ortho-dihydroxylated styrene resulted in formation of protocatechuic aldehyde and formic acid, which upon oxidation results in protocatechuate. However, an A-ring cleavage mechanism of quercetin in P. putida, yielding protocatechuate and oxaloacetate, has previously been proposed (38, 39). Justesen and Arrigoni (24), based on ESI-MS fragmentation patterns of quercetin, suggested the formation of 3,4-dihydroxybenzaldehyde and protocatechuate. Protocatechuate, the conserved B-ring degradation product, has been previously shown to serve as a sole carbon source for some pseudomonads and rhizobia after conversion to succinyl coenzyme A and acetyl coenzyme A via 3-oxoadipate and enters the TCA cycle (35). Protocatechuate has also been implicated as a central intermediate in the degradation of toluene, DDT, biphenyls, benzoate, 4-methoxy benzoate, 2,4-dichlorobenzoate, phenanthrene, phthalate, and vanillin and in the biosynthesis of phenylalanine. C-ring cleavage of quercetin and other nod gene-inducing flavonoids by Rhizobia sp., yielding phloroglucinol and protocatechuate as breakdown intermediates under aerobic conditions, is known to yield protocatechuate (38, 39), which enters the energy-yielding TCA cycle via a meta-cleavage pathway.
Understanding gained from this work will be useful in studying the degradation and modification of natural products from plants. Toward this end, genes involved in this pathway are being characterized.
B.V.S.P. was supported by a Research Scholarship from the National University of Singapore.
|
|
|---|
4-steroid intermediate. J. Lipid Res. 30:10331039.[Abstract]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»